Physician profile
Roberto Calderon
NPI 1942297825
$3,355.92
in general payments reported to CMS, 2019-2025
23 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,083 · 2020: $1,347 · 2021: $488 · 2023: $62.51 · 2024: $134 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $525.62 | 2019-2021 | |
| Novo Nordisk INC | $465.85 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $408.10 | 2019-2021 | |
| Amgen INC. | $242.32 | 2019-2021 | |
| Lilly USA, LLC | $219.99 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $217.22 | 2019-2021 | |
| Amarin Pharma, INC. | $206.95 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $205.77 | 2019-2020 | |
| Pfizer INC. | $152.76 | 2020-2021 | |
| Gilead Sciences, INC. | $144.62 | 2019-2024 | |
| Glaxosmithkline, LLC. | $111.27 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $96.76 | 2019-2021 | |
| Abbvie INC. | $89.40 | 2021-2025 | |
| Exact Sciences Corporation | $74.72 | 2023-2025 | Cologuard Collection Kit |
| Scpharmaceuticals INC. | $27.49 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $26.94 | 2020 | |
| Janssen Pharmaceuticals, INC | $25.77 | 2019 | |
| Radius Health, INC. | $22.65 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $20.54 | 2019 | |
| Inspire Medical Systems, INC. | $19.13 | 2025 | Inspire |
| Vertical Pharmaceuticals, LLC | $19.01 | 2019 | |
| Ironwood Pharmaceuticals, INC | $18.96 | 2020 | |
| Esperion Therapeutics, INC. | $14.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Calderon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.